NCT06932289View on ClinicalTrials.gov

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

NANot yet recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

May 1, 2029

Conditions
NAFLD (Nonalcoholic Fatty Liver Disease)
Interventions
DIETARY_SUPPLEMENT

Mediterranean diet (MED), high-fat/low carb diet (HF/LC), and low-fat diet (LF)

Participants will be randomized to either Mediterranean diet (MED), high-fat/low carb diet (HF/LC), or low-fat diet (LF).

DEVICE

The integrated sweat sensor and vascular sensor (wearable)

The integrated sweat sensor and vascular sensor will be worn of each diet period.

DEVICE

continuous glucose monitor (CGM)

A continuous glucose monitor (CGM) will be placed on the patients during each diet period.

Trial Locations (1)

90073

Va Greater Los Angeles Healthcare System, Los Angeles

All Listed Sponsors
lead

VA Greater Los Angeles Healthcare System

FED

NCT06932289 - Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions | Biotech Hunter | Biotech Hunter